| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |